Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | sodium bile acid cotransporter | solute carrier family 10 (sodium/bile acid cotransporter), member 1 | 349 aa | 283 aa | 32.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0246 | 0.5055 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.0304 | 0.786 | 1 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0246 | 0.5055 | 1 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0316 | 0.847 | 0.8436 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0304 | 0.786 | 1 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0316 | 0.847 | 0.6906 |
Onchocerca volvulus | 0.0348 | 1 | 0.5 | |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.0304 | 0.786 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.847 | 0.6906 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0246 | 0.5055 | 1 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0246 | 0.5055 | 0.6432 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0316 | 0.847 | 0.8436 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0304 | 0.786 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0304 | 0.786 | 0.7812 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0304 | 0.786 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0316 | 0.847 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0304 | 0.786 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0316 | 0.847 | 0.8436 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0348 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0246 | 0.5055 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.0348 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0201 | 0.2831 | 0.2669 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0304 | 0.786 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0348 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0316 | 0.847 | 0.8436 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.3 uM | In vitro inhibition of taurocholate binding to liver bile acid transporter expressed in CHO-cells | ChEMBL. | 15582416 |
IC50 (binding) | = 0.3 uM | In vitro inhibition of taurocholate binding to liver bile acid transporter expressed in CHO-cells | ChEMBL. | 15582416 |
IC50 (binding) | = 0.9 uM | In vitro inhibition of taurocholate binding to human ileal bile acid transporter expressed in CHO-cells | ChEMBL. | 15582416 |
IC50 (binding) | = 0.9 uM | In vitro inhibition of taurocholate binding to human ileal bile acid transporter expressed in CHO-cells | ChEMBL. | 15582416 |
Max (functional) | = 44 % | Percent max value relative to glycodeoxycholic acid in Xenopus laevis oocytes expressing human ileal bile acid transporter | ChEMBL. | 15582416 |
Max (functional) | = 44 % | Percent max value relative to glycodeoxycholic acid in Xenopus laevis oocytes expressing human ileal bile acid transporter | ChEMBL. | 15582416 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.